Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Ipilimumab in Uveal Melanoma: NCT07501117 Clinical Landscape Report 2026
18 September 2026
NCT07501117 clinical landscape for Uveal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant Human IL12/15-PDL1B Herpes simplex type I oncolytic virus(Vero cell)(Virogin) in Non-Muscle Invasive Bladder Neoplasms: NCT07505615 Clinical Landscape Report 2026
18 September 2026
NCT07505615 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Ivosidenib in Acute myeloid leukaemia with 11q23 abnormality: NCT07507760 Clinical Landscape Report 2026
18 September 2026
NCT07507760 clinical landscape for Acute myeloid leukaemia with 11q23 abnormality: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Equecabtagene Autoleucel in Relapse multiple myeloma: NCT07510100 Clinical Landscape Report 2026
18 September 2026
NCT07510100 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Metastatic melanoma: NCT07504796 Clinical Landscape Report 2026
18 September 2026
NCT07504796 clinical landscape for Metastatic melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Universal allogeneic anti-CD19/BCMA CAR T-cells(The Children's Hospital of Zhejiang University School of Medicine) in Granulomatosis With Polyangiitis: NCT07507201 Clinical Landscape Report 2026
18 September 2026
NCT07507201 clinical landscape for Granulomatosis With Polyangiitis: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Pelcitoclax in Acute Myeloid Leukemia: NCT07508982 Clinical Landscape Report 2026
18 September 2026
NCT07508982 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
U96-CAR-T-Cells(The First Affiliated Hospital of Soochow University) in B-Cell Leukemia: NCT07511426 Clinical Landscape Report 2026
18 September 2026
NCT07511426 clinical landscape for B-Cell Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Axatilimab-csfr in Acute Myeloid Leukemia: NCT07511062 Clinical Landscape Report 2026
18 September 2026
NCT07511062 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YK012 in Systemic Lupus Erythematosus: NCT07512947 Clinical Landscape Report 2026
18 September 2026
NCT07512947 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Teclistamab in Refractory Multiple Myeloma: ISRCTN50499387 Clinical Landscape Report 2026
18 September 2026
ISRCTN50499387 clinical landscape for Refractory Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Metformin Hydrochloride in Psoriasis vulgaris: NCT07516821 Clinical Landscape Report 2026
18 September 2026
NCT07516821 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.